Xenotransplantation: Critical Care Nurses Experience and Future Involvement

Activity Summary

Required reading for all learners: Implicit Bias impacts patient outcomes

With recent advances in genetic modification, xenotransplantation has become a promising option to address the organ shortage crisis. After the establishment of a Manufactured Organ Research Facility at NYU Langone Health, two clinical trials were conducted in which brain-dead decedents received transplanted porcine organs. The purpose of this session is to describe the development in the field of xenotransplantation, the implications for nursing research and critical care nursing practice. Pharmacology content = 10%.

Objectives

Review the history of xenotransplantation through current state.
Describe nursing involvement in xenotransplant research.
Discuss the critical care nursing aspects of xenotransplant research through a case study approach.

Continuing Education Disclosure Statement

Criteria for Awarding Contact Hours

Learners must complete the entire activity and the associated evaluation AND read Implicit Bias impacts patient outcomes. No partial credit will be awarded.

Accreditation

American Association of Critical-Care Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Provider approved by the California Board of Registered Nursing, Provider number CEP 1036, for {contactHours} contact hours.

Disclosures

The Nurse Planner has determined that no individuals with the ability to control content of this activity have relevant relationships with ineligible companies.

Activities with pharmacotherapeutic credit are to assist the APRN in fulfilling their education requirements for licensure and certification renewals.

Refund Policy

Continuing Education Activities are nonrefundable.